Ven Bio Partners LLC Portfolio Holdings

Ven Bio Partners LLC

  • $93.4 Million
  • Q1 2025

Ven Bio Partners LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $93.4 Million distributed in 7 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Pharvaris N.V. with a value of $67.3M, Harmony Biosciences Holdings, Inc. with a value of $16.2M, Alx Oncology Holdings Inc with a value of $6.01M, Lyell Immunopharma, Inc. with a value of $3.84M, and Acelyrin Inc with a value of $0.

Examining the 13F form we can see an decrease of $28.1M in the current position value, from $122M to 93.4M.

Ven Bio Partners LLC is based out at San Francisco, CA

Below you can find more details about Ven Bio Partners LLC portfolio as well as his latest detailed transactions.

Portfolio value $93.4 Million
Healthcare: $93.4 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 7
  • Current Value $93.4 Million
  • Prior Value $122 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Ven Bio Partners LLC Portfolio

Follow Ven Bio Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ven Bio Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ven Bio Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email